MICHAEL COMO: Open Payments
NPI 1861126120 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 26 payments from 9 companies in 2025. Trend: 2023 $124 · 2024 $875 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $208 |
| ABBVIE INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Almatica Pharma LLC | 2 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| Exact Sciences Corporation | 1 | $21 |
Products named: GEMTESA, AIRSUPRA, UBRELVY, Jornay PM, JARDIANCE, MOUNJARO, LOREEV XR, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
